Burden of illness, visual impairment and health resource utilisation of patients with neovascular age‐related macular degeneration: results from the UK cohort of a five‐country cross‐sectional study

AUTOR(ES)

Lotery, Andrew

FONTE

BMJ Group

Documentos Relacionados

• Pegaptanib and ranibizumab for neovascular age‐related macular degeneration: a systematic review
• Age-related macular degeneration: armed against ARMD
• Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study.
• Treatment of age-related macular degeneration
• Treatment of age-related macular degeneration